Published in Nucleic Acids Res on January 15, 2013
miRNA dysregulation in cancer: towards a mechanistic understanding. Front Genet (2014) 1.25
Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies. Front Cell Neurosci (2013) 1.04
A Uniform System for the Annotation of Vertebrate microRNA Genes and the Evolution of the Human microRNAome. Annu Rev Genet (2015) 1.02
Emerging roles of competing endogenous RNAs in cancer: insights from the regulation of PTEN. Mol Cell Biol (2013) 1.01
Re-evaluation of the roles of DROSHA, Exportin 5, and DICER in microRNA biogenesis. Proc Natl Acad Sci U S A (2016) 0.95
A multiple-alignment based primer design algorithm for genetically highly variable DNA targets. BMC Bioinformatics (2013) 0.94
Analysis of Nearly One Thousand Mammalian Mirtrons Reveals Novel Features of Dicer Substrates. PLoS Comput Biol (2015) 0.89
Next-generation sequencing of small RNAs from inner ear sensory epithelium identifies microRNAs and defines regulatory pathways. BMC Genomics (2014) 0.84
The germline of the malaria mosquito produces abundant miRNAs, endo-siRNAs, piRNAs and 29-nt small RNAs. BMC Genomics (2015) 0.84
A general approach to high-yield biosynthesis of chimeric RNAs bearing various types of functional small RNAs for broad applications. Nucleic Acids Res (2015) 0.84
Analysis of organ-enriched microRNAs in plasma as an approach to development of Universal Screening Test: feasibility study. J Transl Med (2013) 0.83
Dietary RNAs: New Stories Regarding Oral Delivery. Nutrients (2015) 0.82
MicroRNA-23b regulates cellular architecture and impairs motogenic and invasive phenotypes during cancer progression. Bioarchitecture (2014) 0.82
MicroRNAs in normal and psoriatic skin. Physiol Genomics (2013) 0.82
Loss of functional Dicer in mouse radial glia cell-autonomously prolongs cortical neurogenesis. Dev Biol (2013) 0.81
Global identification of target recognition and cleavage by the Microprocessor in human ES cells. Nucleic Acids Res (2014) 0.81
A deeply conserved, noncanonical miRNA hosted by ribosomal DNA. RNA (2015) 0.81
Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus. World J Virol (2015) 0.79
Regulatory RNAs and control of epigenetic mechanisms: expectations for cognition and cognitive dysfunction. Epigenomics (2015) 0.79
Expression of Flotilin-2 and Acrosome Biogenesis Are Regulated by MiR-124 during Spermatogenesis. PLoS One (2015) 0.76
The Drosophila Helicase MLE Targets Hairpin Structures in Genomic Transcripts. PLoS Genet (2016) 0.76
Intercellular transfer of small RNAs from astrocytes to lung tumor cells induces resistance to chemotherapy. Oncotarget (2016) 0.75
Prediction of mature microRNA and piwi-interacting RNA without a genome reference or precursors. Int J Mol Sci (2015) 0.75
MicroRNAs as regulatory elements in psoriasis. Open Med (Wars) (2016) 0.75
MicroRNA-independent functions of DGCR8 are essential for neocortical development and TBR1 expression. EMBO Rep (2017) 0.75
Dicer Regulates the Balance of Short-Lived Effector and Long-Lived Memory CD8 T Cell Lineages. PLoS One (2016) 0.75
Discrimination of the expression of paralogous microRNA precursors that share the same major mature form. PLoS One (2014) 0.75
Bias in recent miRBase annotations potentially associated with RNA quality issues. Sci Rep (2017) 0.75
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
miRBase: tools for microRNA genomics. Nucleic Acids Res (2007) 38.61
The nuclear RNase III Drosha initiates microRNA processing. Nature (2003) 35.49
MicroRNAs modulate hematopoietic lineage differentiation. Science (2003) 30.05
A uniform system for microRNA annotation. RNA (2003) 20.28
The Microprocessor complex mediates the genesis of microRNAs. Nature (2004) 17.70
Processing of primary microRNAs by the Microprocessor complex. Nature (2004) 14.59
Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes. Nature (2008) 10.71
The UCSC Genome Browser Database: update 2009. Nucleic Acids Res (2008) 10.31
Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes. Nature (2008) 10.11
Intronic microRNA precursors that bypass Drosha processing. Nature (2007) 9.65
The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila. Cell (2007) 7.70
Mammalian microRNAs: experimental evaluation of novel and previously annotated genes. Genes Dev (2010) 7.14
Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs. Genes Dev (2008) 7.07
A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature (2010) 6.37
A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science (2010) 5.84
A human snoRNA with microRNA-like functions. Mol Cell (2008) 5.84
miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res (2011) 5.83
Mammalian mirtron genes. Mol Cell (2007) 5.75
DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature (2011) 3.90
Mammalian microRNAs derived from genomic repeats. Trends Genet (2005) 3.60
Posttranscriptional crossregulation between Drosha and DGCR8. Cell (2009) 3.54
DNA methylation and SETDB1/H3K9me3 regulate predominantly distinct sets of genes, retroelements, and chimeric transcripts in mESCs. Cell Stem Cell (2011) 3.10
Endogenous small interfering RNAs in animals. Nat Rev Mol Cell Biol (2008) 3.00
Genome-wide identification of Ago2 binding sites from mouse embryonic stem cells with and without mature microRNAs. Nat Struct Mol Biol (2011) 2.85
Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. Mol Cell (2011) 2.73
Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis. Proc Natl Acad Sci U S A (2010) 2.67
A family of human microRNA genes from miniature inverted-repeat transposable elements. PLoS One (2007) 2.63
Deep annotation of Drosophila melanogaster microRNAs yields insights into their processing, modification, and emergence. Genome Res (2010) 2.56
MicroRNA biogenesis via splicing and exosome-mediated trimming in Drosophila. Mol Cell (2010) 1.78
Discovery of hundreds of mirtrons in mouse and human small RNA data. Genome Res (2012) 1.63
Biogenic mechanisms and utilization of small RNAs derived from human protein-coding genes. Nat Struct Mol Biol (2011) 1.51
The function of RNAi in plant development. Cold Spring Harb Symp Quant Biol (2006) 1.23
Common and distinct patterns of terminal modifications to mirtrons and canonical microRNAs. RNA (2011) 1.20
Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer. Nat Med (2011) 2.49
Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol (2008) 2.38
The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci U S A (2009) 2.29
Unique localization of circulating tumor cells in patients with hepatic metastases. J Clin Oncol (2009) 1.99
Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases. Br J Haematol (2005) 1.86
Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease. Blood (2009) 1.71
HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome? J Acquir Immune Defic Syndr (2004) 1.64
Brief communication: rituximab in HIV-associated multicentric Castleman disease. Ann Intern Med (2007) 1.54
Not so SMART? Lancet Infect Dis (2009) 1.43
Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control study. J Acquir Immune Defic Syndr (2004) 1.42
HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease. Clin Infect Dis (2008) 1.42
HIV, hepatitis B and hepatitis C coinfection in Kenya. AIDS (2008) 1.34
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy. Genome Res (2011) 1.32
A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy. Ann Intern Med (2005) 1.31
A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI). J Hepatol (2012) 1.31
MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors. PLoS One (2012) 1.27
Protease inhibitors potentiate chemotherapy-induced neutropenia. Blood (2004) 1.26
miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts. Nucleic Acids Res (2013) 1.21
Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease. J Clin Oncol (2011) 1.18
Kinases as targets in the treatment of solid tumors. Cell Signal (2010) 1.17
Broader implications of a stage-guided stratified therapeutic approach for AIDS-related Kaposi's sarcoma. J Clin Oncol (2013) 1.17
A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma. AIDS (2003) 1.15
The role of pseudokinases in cancer. Cell Signal (2012) 1.13
Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration. Clin Lung Cancer (2010) 1.08
Influence of plasma processing on recovery and analysis of circulating nucleic acids. PLoS One (2013) 1.08
Protein kinases as targets for cancer treatment. Pharmacogenomics (2007) 1.06
An open-label assessment of TMC 125--a new, next-generation NNRTI, for 7 days in HIV-1 infected individuals with NNRTI resistance. AIDS (2003) 1.05
Why does cytotoxic chemotherapy cure only some cancers? Nat Clin Pract Oncol (2008) 1.04
The risks and incidence of K65R and L74V mutations and subsequent virologic responses. Clin Infect Dis (2008) 1.03
Immunologic recovery in survivors following chemotherapy for AIDS-related non-Hodgkin lymphoma. Blood (2008) 1.03
Clinical outcome in resistant HIV-2 infection treated with raltegravir and maraviroc. Antiviral Res (2010) 1.02
Emerging roles of competing endogenous RNAs in cancer: insights from the regulation of PTEN. Mol Cell Biol (2013) 1.01
FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's disease. Eur J Nucl Med Mol Imaging (2008) 1.01
Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease. Blood (2007) 1.01
[18F]-3'Deoxy-3'-fluorothymidine positron emission tomography and breast cancer response to docetaxel. Clin Cancer Res (2011) 1.00
Should cervical cancer be an acquired immunodeficiency syndrome-defining cancer? J Clin Oncol (2006) 1.00
Altered tissue 3'-deoxy-3'-[18F]fluorothymidine pharmacokinetics in human breast cancer following capecitabine treatment detected by positron emission tomography. Clin Cancer Res (2009) 0.98
Antigen presentation and the role of dendritic cells in HIV. Curr Opin Infect Dis (2004) 0.97
Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study. Breast Cancer Res Treat (2012) 0.96
The efficacy of percutaneous vertebroplasty for vertebral metastases associated with solid malignancies. Eur J Cancer (2009) 0.96
IDH mutations in tumorigenesis and their potential role as novel therapeutic targets. Future Oncol (2013) 0.95
Peritoneal disease in breast cancer: a specific entity with an extremely poor prognosis. Eur J Cancer (2009) 0.94
HIV and AIDS in the People's Republic of China: a collaborative review. Int J STD AIDS (2003) 0.94
Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients. Pharmacogenomics (2009) 0.94
Serum molecular signatures of weight change during early breast cancer chemotherapy. Clin Cancer Res (2009) 0.93
Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy. AIDS (2008) 0.93
Expansion of CD8+ cytotoxic T cells in vitro and in vivo using MHC class I tetramers. Tumour Biol (2007) 0.93
Two-stage resection for bilobar colorectal liver metastases: R0 resection is the key. Ann Surg Oncol (2011) 0.92
Highly active antiretroviral therapy and human immunodeficiency virus-associated primary cerebral lymphoma. J Natl Cancer Inst (2006) 0.92
Downregulation of microRNA-515-5p by the estrogen receptor modulates sphingosine kinase 1 and breast cancer cell proliferation. Cancer Res (2013) 0.91
The efficacy of axillary ultrasound in the detection of nodal metastasis in breast cancer. AJR Am J Roentgenol (2013) 0.91
The p53 miRNA interactome and its potential role in the cancer clinic. Epigenomics (2013) 0.90
Hepatitis C infection is not associated with systemic HIV-associated non-Hodgkin's lymphoma: a cohort study. Int J Cancer (2005) 0.90
A microRNA meta-signature for pancreatic ductal adenocarcinoma. Expert Rev Mol Diagn (2014) 0.90
Thyroid dysfunction and relationship to antiretroviral therapy in HIV-positive individuals in the HAART era. J Acquir Immune Defic Syndr (2009) 0.90
The dual function of KSR1: a pseudokinase and beyond. Biochem Soc Trans (2013) 0.90
The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia. Eur J Haematol (2009) 0.90
Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancer. Breast Cancer Res Treat (2015) 0.90
Role of CYP2D6 testing in selection of endocrine therapy for breast cancer. Pharmacogenomics (2007) 0.90
Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapy. Clin Lymphoma (2003) 0.89
Kinetic filtering of [(18)F]Fluorothymidine in positron emission tomography studies. Phys Med Biol (2010) 0.89
The nucleoside backbone affects durability of efavirenz- or nevirapine-based highly active antiretroviral therapy in antiretroviral-naive individuals. J Acquir Immune Defic Syndr (2009) 0.89
[11C]choline positron emission tomography in estrogen receptor-positive breast cancer. Clin Cancer Res (2009) 0.89
The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasis. Mol Diagn Ther (2012) 0.88
Expression of the common heat-shock protein receptor CD91 is increased on monocytes of exposed yet HIV-1-seronegative subjects. J Leukoc Biol (2005) 0.87
CK1delta modulates the transcriptional activity of ERalpha via AIB1 in an estrogen-dependent manner and regulates ERalpha-AIB1 interactions. Nucleic Acids Res (2009) 0.87
Von Hippel-Lindau methylation status in patients with multiple myeloma: a potential predictive factor for the development of bone disease. Clin Lymphoma Myeloma (2009) 0.87
Loss of miR-126 is crucial to pancreatic cancer progression. Expert Rev Anticancer Ther (2012) 0.87
Reduced dissemination of circulating tumor cells with no-touch isolation surgical technique in patients with pancreatic cancer. JAMA Surg (2014) 0.86
PARP inhibitors in BRCA1-/BRCA2-associated and triple-negative breast cancers. Future Oncol (2010) 0.86
Circulating tumor cells and plasma DNA analysis in patients with indeterminate early or metastatic breast cancer. Biomark Med (2011) 0.86
MicroRNAs in the cancer clinic. Front Biosci (Elite Ed) (2013) 0.86
The phosphorylated membrane estrogen receptor and cytoplasmic signaling and apoptosis proteins in human breast cancer. Cancer (2008) 0.86
Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer. Nat Rev Urol (2011) 0.86
Biological basis of [¹¹C]choline-positron emission tomography in patients with breast cancer: comparison with [¹⁸F]fluorothymidine positron emission tomography. Nucl Med Commun (2011) 0.85
Resolution of AIDS-related Castleman's disease with anti-CD20 monoclonal antibodies is associated with declining IL-6 and TNF-alpha levels. Leuk Lymphoma (2004) 0.85
The effect of statins on HIV rebound and blips. J Acquir Immune Defic Syndr (2005) 0.85
Prognostic role of lemur tyrosine kinase-3 germline polymorphisms in adjuvant gastric cancer in Japan and the United States. Mol Cancer Ther (2013) 0.85
Use of mathematical models to understand anticancer drug delivery and its effect on solid tumors. Pharmacogenomics (2011) 0.85
Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway. Breast Cancer Res (2014) 0.84
Blood-based miRNAs as noninvasive diagnostic and surrogative biomarkers in colorectal cancer. Expert Rev Mol Diagn (2013) 0.84
Germ-cell tumors. N Engl J Med (2007) 0.84
Hepatocellular cancer in HIV-infected individuals: tomorrow's problem? Expert Rev Anticancer Ther (2006) 0.84
Circulating tumour cells as more than prognostic markers. Lancet Oncol (2009) 0.83
The evolution of coreceptor tropism in HIV-infected patients interrupting suppressive antiretroviral therapy. Clin Infect Dis (2011) 0.83
microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinoma. Expert Rev Anticancer Ther (2011) 0.83
Lemur tyrosine kinase-3 (LMTK3) in cancer and evolution. Oncotarget (2011) 0.83
Conservation of unique cell-surface CD antigen mosaics in HIV-1-infected individuals. Blood (2005) 0.83
miRNAs in breast cancer: ready for real time? Pharmacogenomics (2012) 0.83
Is the detection of circulating tumor cells in locally advanced pancreatic cancer a useful prognostic marker? Expert Rev Mol Diagn (2013) 0.82
MicroRNA-23b regulates cellular architecture and impairs motogenic and invasive phenotypes during cancer progression. Bioarchitecture (2014) 0.82
Circulating peripheral blood mononuclear cells exhibit altered miRNA expression patterns in pancreatic cancer. Expert Rev Mol Diagn (2013) 0.81
A tale of three Hs: HPV, HIV & HAART. Future Oncol (2006) 0.81
Chemotherapy for advanced cholangiocarcinoma: what is standard treatment? Future Oncol (2006) 0.81
Triple-class antiretroviral agent resistance in a large cohort: prevalence and clinical outcomes. Arch Intern Med (2008) 0.81
A trial of caspofungin salvage treatment in PCP pneumonia. Thorax (2010) 0.81
Brain metastases associated with germ cell tumors may be treated with chemotherapy alone. Cancer (2014) 0.81
Towards a clinical use of miRNAs in pancreatic cancer biopsies. Expert Rev Mol Diagn (2013) 0.81
Mistletoe: for cancer or just for Christmas? Lancet Oncol (2013) 0.81
Recent advances in the systemic management of colorectal cancer. Future Oncol (2006) 0.81